Elixir Medical is committed to transforming care of patients with heart and vascular disease through innovation.

Since 2005, the company has continually sought to improve the treatment of vascular disease with:

- Drug-eluting coronary stent systems (DES)
- Fully resorbable drug-eluting scaffold systems (BRS)
- Drug-eluting coronary bioadaptor systems

Its latest innovation — the DynamX™ Coronary Bioadaptor System — is designed to be a significant advancement beyond drug-eluting stents (DES).

Elixir Medical’s innovations are designed to make a meaningful change in patients’ lives. The company does not simply want to engineer a better medical device. Saving lives and helping patients enjoy their daily life is what drives us every day.

Life Sciences

Health Care

Biotechnology

Medical Devices

Elixir Medical Corporation

Motasim Sirhan

Max Muhs

Angela C.

Jennifer Balester

Al P.

Erin Mazzone

Candace Elek

Vinayak Bhat

Brian McBerry

Ashley B.

Sean Fryman

Alex Nepogodiev

Research and Development

Leadership Team

Operations and Quality Management

Sales and Marketing

Operations Team

Finance and Accounting

Teams at Elixir Medical Corporation